# Tvardi Therapeutics, Inc.: Form 8-K, filed Aug 1, 2024

- Company: [Tvardi Therapeutics, Inc.](/companies/tvrd.md) (CIK 1346830)
- Form: 8-K
- Filed: 2024-08-01
- Accepted by EDGAR: Aug 1, 2024, 16:15 ET
- Period: 2024-07-31
- Accession: 0001104659-24-084911
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1346830/000110465924084911/tm2420653d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1346830/000110465924084911/

## Items reported

- Item 3.01: Delisting notice

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1346830/000110465924084911/tm2420653d1_8k.htm

Filed Aug 1, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-084911. Last ingested by Listed: Oct 24, 2026, 15:11 ET. No prices; not investment advice.